ClinicalTrials.gg
Active, not recruitingNCT04212143Updated Oct 22, 2026

Central Blood Pressure and Pulse Wave Velocity in Kidney Transplant Recipients

An observational study in End Stage Renal Disease, sponsored by Children's National Research Institute. Active, not recruiting at 1 site in United States. Open to participants aged 3 Years to 21 Years. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Children's National Research Institute · Observational

How we know

Updated Oct 22, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
3 Years to 21 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 765 studies in Kidney Failure, Chronic with a site in United States — 65 open to participants now, 96 under way, 9 of them phase 3. Kidney Failure, Chronic · United States.

Planned enrollment
50th of 121
150 · median 100
Started
2021
with 30 others
Observational
121 of 765
13 open now
Primary completion
2027-07
later than 51 of 95 live
Registered
576th of 765
by date

Among the 765 studies in Kidney Failure, Chronic with a site in United States, this one is the 50th largest by planned enrollment of the 121 observational ones that give a count, is one of 31 that started in 2021, is one of 121 observational ones, reaches primary completion later than 51 of the 95 other live ones, and was the 576th registered.

Kidney Failure, Chronic

2,115 studies on the registry are indexed under Kidney Failure, Chronic; 277 are open to participants now.

Browse Kidney Failure, Chronic studies →

Open to participants now

65 of the 765 studies in Kidney Failure, Chronic with a site in United States are open now. Recruiting first, the newest first:

60 more — sign in →

All 65 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 170 Kidney Failure, Chronic studies recruiting now, 109 (64%) set no upper age limit and 32 (19%) stop at 75 or younger; 18 take children under 18; 22 take healthy volunteers.

This study: 3 Years to 21 Years · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 765 studies in Kidney Failure, Chronic with a site in United States, or all of them as a file.
02

Study summary

An observational cohort study will be conducted to non-invasively investigate central blood pressure and pulse wave velocity in children with kidney disease and controls. Using an oscillometric monitor, the investigators aim to non-invasively obtain the central blood pressure and pulse wave velocity (PWV), or arterial stiffness, of children with kidney disease. The investigators will also enroll age- and race-matched healthy controls and measure the same parameters for comparison. In addition, the investigators will measure PWV by standard arterial tonometry method in a subset of patients.

Read the detailed description

The specific aims of the study are as follows:

  1. Using an oscillometric blood pressure monitor, the investigators aim to non-invasively obtain the central blood pressure and pulse wave velocity (PWV), or arterial stiffness, of children with kidney disease.
  2. Measure oscillometric central blood pressure and PWV in age and race matched healthy children.
  3. Measure PWV by standard arterial tonometry method in a subset of patients, and compare these measurements to the PWV measured using the oscillometric device.
  4. Measure body composition of patients and controls (Body Mass Index, Waist-to-Height ratio, %body fat, and mid-arm muscle circumference) to see how this relates to central blood pressure and PWV.
03

Conditions studied

  • End Stage Renal Disease
04

Who can participate

Ages eligible
3 Years to 21 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

pediatric kidney transplant recipients and healthy controls

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • kidney transplant recipients who are at least 6 months post-transplant
  • healthy children matched for age sex and race

Exclusion criteria

Exclusion Criteria:

  • age less than 3 years
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • children with kidney disease

    Kidney transplant recipients age 3 to 21 years

    Other: there is no intervention

  • healthy control

    Healthy children age 3 to 21 years

    Other: there is no intervention

Interventions

  • Otherthere is no intervention

    There is no intervention in this study. It is observational only.

06

What researchers measure

Primary outcomes

  1. Oscillometric central blood pressure

    Central blood pressure as measured by oscillometric blood pressure device

    Time frame: cross-sectional measurement performed in patients who are between 6 months to 10 years post-transplant

  2. Oscillometric pulse wave velocity

    Pulse wave velocity as measured by oscillometric blood pressure device

    Time frame: cross-sectional measurement performed in patients who are anywhere between 6 months to 10 years post-transplant

Secondary outcomes

  1. Body mass index (BMI) in kg/m2

    weight measured in kg and height measured in cm will be combined to determine BMI (kg/m2)

    Time frame: cross-sectional measurement performed in patients who are anywhere between 6 months to 10 years post-transplant

  2. Waist circumference (cm)

    waist circumference will be measured in cm using a flexible tape measure

    Time frame: cross-sectional measurement performed in patients who are anywhere between 6 months to 10 years post-transplant

  3. Mid arm circumference (cm)

    Mid arm circumference will be measured in cm using a flexible tape measure

    Time frame: cross-sectional measurement performed in patients who are anywhere between 6 months to 10 years post-transplant

07

Study locations

1 site
  • Children's National Medical Cetner
    Washington D.C., District of Columbia 20010, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2021 (actual). Primary completion is estimated for Jul 2027, 72 months after the start.

Of 132 non-industry observational studies under Kidney Failure, Chronic, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 62. This study's planned 72 months is above that.

Counting every sponsor, half of 151 studies reached it within 29 months; a quarter within 11 and three quarters within 62.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 22, 2026: primary completion Jul 2026 → Jul 2027 and completion Jul 2026 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 23, 2019
First posted
Dec 26, 2019
StartActual
Jul 1, 2021
Primary completionEst.
Jul 1, 2027was Jul 2026
CompletionEst.
Dec 1, 2027was Jul 2026
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jul 1, 2026→Jul 1, 2027
Oct 22, 2026
Study completion
Jul 1, 2026→Dec 1, 2027
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    Primary completion Jul 1, 2026→Jul 1, 2027
    Study completion Jul 1, 2026→Dec 1, 2027
    + 2 other changes: verification date and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04212143
Responsible party
Kristen Sgambat (Clinical Dietitian IV, Children's National Research Institute) — Principal investigator
First posted
Dec 26, 2019
Start date
Jul 1, 2021
Primary completion
Jul 1, 2027 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Oct 22, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion